###begin article-title 0
Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure
###end article-title 0
###begin p 1
Conceived and designed the experiments: MAS. Performed the experiments: HgL QC SLR AL SLS HF BDH EJL. Analyzed the data: HgL JAW AL SLS XZ NPZ HF DWF RJC MLV JAM BDH EJL MAS. Contributed reagents/materials/analysis tools: DWF. Wrote the paper: HgL SLS BDH EJL MAS.
###end p 1
###begin p 2
Current address: Department of Medicine, Division of Cardiology, Virginia Commonwealth University, and McGuire DVAMC, Richmond, Virginia, United States of America
###end p 2
###begin p 3
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
While considerable evidence supports the causal relationship between increases in c-Myc (Myc) and cardiomyopathy as a part of a "fetal re-expression" pattern, the functional role of Myc in mechanisms of cardiomyopathy remains unclear. To address this, we developed a bitransgenic mouse that inducibly expresses Myc under the control of the cardiomyocyte-specific MHC promoter. In adult mice the induction of Myc expression in cardiomyocytes in the heart led to the development of severe hypertrophic cardiomyopathy followed by ventricular dysfunction and ultimately death from congestive heart failure. Mechanistically, following Myc activation, cell cycle markers and other indices of DNA replication were significantly increased suggesting that cell cycle-related events might be a primary mechanism of cardiac dysfunction. Furthermore, pathological alterations at the cellular level included alterations in mitochondrial function with dysregulation of mitochondrial biogenesis and defects in electron transport chain complexes I and III. These data are consistent with the known role of Myc in several different pathways including cell cycle activation, mitochondrial proliferation, and apoptosis, and indicate that Myc activation in cardiomyocytes is an important regulator of downstream pathological sequelae. Moreover, our findings indicate that the induction of Myc in cardiomyocytes is sufficient to cause cardiomyopathy and heart failure, and that sustained induction of Myc, leading to cell cycle re-entry in adult cardiomyocytes, represents a maladaptive response for the mature heart.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Komuro1">[1]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Izumo1">[2]</xref>
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Pollack1">[3]</xref>
###xml 623 626 623 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Johnston1">[4]</xref>
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Pelengaris1">[7]</xref>
###xml 915 918 915 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Grandori1">[5]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Karlsson1">[10]</xref>
c-Myc (Myc) is highly expressed in fetal, proliferating cardiac myocytes. However, soon after birth, myocytes cease to divide corresponding with the downregulation of Myc [1]. Interestingly, while Myc is expressed at very low levels in the adult myocardium under normal physiological conditions, it is upregulated rapidly in response to virtually all hypertrophic stimuli and leads to hypertrophy rather than hyperplasia [2], [3]. Myc encodes a transcription factor that, as part of a heterodimeric complex with MAX, regulates the expression of a multitude of genes involved in regulating cellular proliferation and growth [4]-[7]. Consequently, overexpression of Myc is commonly associated with the activation of cell cycle machinery and tumorigenesis. Myc exerts its neoplastic function by inducing autonomous cellular proliferation and cellular growth, blocking differentiation, and inducing genomic instability [5]-[10].
###end p 5
###begin p 6
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Komuro1">[1]</xref>
###xml 228 231 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Pollack1">[3]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Robbins1">[11]</xref>
###xml 427 431 427 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Reiss1">[12]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Kai1">[13]</xref>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Loeffen1">[14]</xref>
###xml 1092 1096 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lucas1">[17]</xref>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Li1">[18]</xref>
###xml 1463 1467 1447 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Li1">[18]</xref>
###xml 1746 1750 1722 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lehman1">[19]</xref>
###xml 1752 1756 1728 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Russell1">[20]</xref>
###xml 436 442 <span type="species:ncbi:9606">humans</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 565 571 <span type="species:ncbi:9606">humans</span>
###xml 1977 1982 <span type="species:ncbi:10090">mouse</span>
In various animal models of cardiomyopathy, the upregulation of Myc is a consistent and early change. For instance, Myc mRNA is dramatically increased several hours after the imposition of pressure overload in animal models [1]-[3]. Notably, similar changes in Myc expression have been reported under other pathological circumstances including myocardial infarction and hypertrophy induced by pharmacological stimulation [11], [12]. In humans, Myc mRNA is increased in hypertrophic cardiomyopathy patients [13]. While the ability to detect chronological changes in humans is limited because samples are obtained postmortem or at biopsy, the consistent detection of Myc expression raises the question of whether the early expression of Myc is necessary or sufficient to induce disease. Moreover, if Myc expression is sufficient to cause disease, it is unclear which Myc-related downstream mechanisms, such as cell cycle re-entry, contribute to cardiomyopathy. In this regard, given that mitochondrial alterations are directly linked to the development of cardiomyopathy and heart failure [14]-[17], it is interesting to note that Myc also plays a role in the maintenance of mitochondrial function [18]. While the mechanism of Myc-regulated mitochondrial function is unclear, the regulation of PGC-1alpha (PPARgamma coactivator-1alpha) appears to be a key factor in this process since Myc induced the biogenesis of mitochondria through a PGC-1alpha-related pathway [18]. PGC-1alpha is a major regulatory molecule of mitochondrial proliferation and induces synthesis of both mitochondrial DNA-encoded and nuclear-encoded mitochondrial peptides. Importantly, the expression of PGC-1alpha is directly associated with the development of cardiomyopathy [19], [20]. Thus, Myc may induce hypertrophic cardiomyopathy though reactivation of the cell cycle machinery and by negatively affecting mitochondrial function. To test this hypothesis, using a newly developed inducible transgenic mouse model, we examined the effect of Myc on the development of cardiomyopathy and heart failure and mechanistically evaluated alterations in cell cycle and mitochondria.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Establishment of MHC-Myc mice
###end title 8
###begin p 9
###xml 675 679 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Valencik1">[21]</xref>
###xml 817 820 813 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Felsher1">[9]</xref>
###xml 1036 1045 1028 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g001">Figure 1A</xref>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
Traditional transgenic mouse models have significant limitations for studying the pathogenic mechanism(s) of cardiomyopathy due to adverse effects of the transgene in development and also limitations in studying the temporal effect of a given transgene in mice that constitutively overexpress the transgene. To circumvent both of these problems and to study the importance of Myc-driven cell cycle re-entry in the pathogenesis of cardiomyopathy, we used a tetracycline-controlled system to generate bitransgenic mice (MHC-Myc) that inducibly overexpress Myc under the control of the alphaMHC gene promoter that drives high transgene expression specifically in cardiomyocytes [21]. To generate MHC-Myc mice, we mated the transgenic line tet-o-Myc, which contains the tetracycline response element adjacent to Myc cDNA [9], with the transgenic line alphaMHC-rtTA (JAM8585), which drives the expression of rtTA in cardiomyocytes. rtTA requires doxycycline to bind tetO and, therefore, the transcription of Myc is activated by doxycycline (Figure 1A). The MHC-Myc mice are derived from heterozygote crosses and, as a result, 75% of the litter is, as expected, composed of non-bitransgenic mice that serve as controls (+/- doxycycline). We have not experienced any issues in the breeding of, nor maintenance, of these mice which remain healthy unless the transgene is activated.
###end p 9
###begin title 10
###xml 33 37 <span type="species:ncbi:10090">mice</span>
The regulation of Myc in MHC-Myc mice.
###end title 10
###begin p 11
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 399 405 <span type="species:ncbi:9986">rabbit</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 589 592 <span type="species:ncbi:10090">OFF</span>
(A) The rtTA molecule is driven by MHC promoter. rtTA requires doxycycline (Dox) for binding to tetO sequence to drive expression of Myc. Without Dox, rtTA remains inactive and Myc expression is not initiated. (B) mRNA level of Myc is measured by RT-PCR after 1 week doxycycline diet. In comparison to the basal level (Myc-OFF). (C) The level of protein expression is analyzed by human Myc specific rabbit monoclonal antibody. The expression of Myc is strongly induced in nuclei of cardiomyocytes by doxycycline diet after 1 week (ON) but no expression of Myc is detected in control mice (OFF).
###end p 11
###begin p 12
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g001">Figure 1B</xref>
###xml 297 306 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g001">Figure 1C</xref>
###xml 173 177 <span type="species:ncbi:10090">Mice</span>
###xml 548 554 <span type="species:ncbi:9986">rabbit</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
To examine the inducible expression of Myc, doxycycline (200 mg/kg) containing diet was provided for 1 week and hearts were collected for the measurement of Myc expression. Mice possessing both transgenes and on doxycycline diet exhibited increased expression of Myc mRNA (Figure 1B) and protein (Figure 1C) compared with the basal level of Myc expression in similar animals that were not fed doxycycline. After 1 week of induction by doxycycline, prominent expression of Myc in the nuclei of cardiomyocytes was detected using an anti-Myc specific rabbit monoclonal antibody. These data clearly demonstrate that Myc expression can be tightly regulated by the doxycycline diet and that there is little/no significant leakiness of Myc expression in the MHC-Myc mice.
###end p 12
###begin title 13
Hypertrophy and heart failure by Myc induction
###end title 13
###begin p 14
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g002">Figure 2C</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 394 397 <span type="species:ncbi:10090">OFF</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
We used 3-4 month old MHC-Myc mice to determine the effect of Myc on adult cardiomyocytes. At baseline, hearts from MHC-Myc mice were indistinguishable in terms of size, histology or echocardiography from littermate control mice. However, the overexpression of Myc, with doxycline-diet in Myc-ON mice, resulted in 100% mortality in 3 weeks (Figure 2C) wherease no mortality was observed in Myc-OFF nor littermate control mice up to 14 months old, which are the oldest MHC-Myc mice in our current colony.
###end p 14
###begin title 15
Increase of Myc expression in adult cardiomyocytes induces cardiomyopathy and heart failure.
###end title 15
###begin p 16
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 392 395 <span type="species:ncbi:10090">OFF</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
(A) Measured heart weights (mg) were normalized to body weight (g). 1 week Myc-ON mice demonstrate about 80% increase of normalized cardiac mass and great than 100% increase is observed after 2 weeks and the dramatic increase of cardiac mass is observed in isolated hearts (B). (C) Myc-ON mice exhibit increased mortality after 2 weeks of Myc induction while no lethality was observed in Myc-OFF mice (n = 12).
###end p 16
###begin p 17
###xml 608 615 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007172-t001">Table 1</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 199 202 <span type="species:ncbi:10090">OFF</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
To characterize the phenotype in the adult Myc-ON mice, cardiac structure and function were assessed by echocardiography after 2 weeks of doxycycline administration (female, 3-4 month old, n = 8 Myc-OFF, n = 5 Myc-ON). Cardiac-restricted temporally-defined overexpression of Myc resulted in a marked increase in LV mass with concentric geometry (increased relative wall thickness), reduced LV fractional shortening, decreased cardiac output, increased myocardial performance index (indicating impaired contraction and relaxation), and left atrial enlargement, suggesting an increase in left atrial pressure (Table 1). Thus, Myc overexpression for 2 weeks produced decompensated hypertrophic cardiomyopathy characterized by impaired systolic and diastolic function. Importantly, single transgenic control mice, which only have either the Myc or the MHC-rtTA gene, on a similar doxycycline diet showed no significant changes in any of the parameters measured.
###end p 17
###begin title 18
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Echocardiographic Analysis of MHC-Myc mice.
###end title 18
###begin p 19
p<0.05.
###end p 19
###begin p 20
p<0.001.
###end p 20
###begin p 21
All data are expressed as the mean+/-SD. Abbreviations: aortic root diameter (AoR), end diastolic dimension (EDD), end systolic dimension (ESD), interventricular septal thickness in diastole (IVSd), left ventricular mass index (LVMI), posterior wall thickness in diastole (PWTd).
###end p 21
###begin p 22
###xml 199 210 199 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g002">Figure 2A,B</xref>
###xml 355 366 355 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g003">Figure 3A&#8211;C</xref>
###xml 416 425 416 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g003">Figure 3D</xref>
###xml 856 864 856 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g004">Figure 4</xref>
###xml 189 192 <span type="species:ncbi:10090">OFF</span>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
Consistent with the echocardiographic data, a two week induction of Myc resulted in an approximately 2-fold increase in gravimetric cardiac mass normalized to body weight compared with Myc-OFF mice (Figure 2A,B). Histological analysis revealed typical hypertrophic changes including myocardial disarray, nuclear atypia and marked increase in fiber width (Figure 3A-C) as well as interstitial deposition of collagen (Figure 3D). One of the most conserved features of cardiac hypertrophy is the re-activation of genes that are normally limited in their expression to the embryonic stage of heart development and these are often used as molecular markers for cardiac hypertrophy. Therefore, we examined hypertrophic changes at the molecular level by measuring two well known marker genes, atrial natriuretic peptide and brain natriuretic peptide. As shown in Figure 4, the expression of both atrial and brain natriuretic peptides was significantly increased after 1 week induction and then decreased after 2 weeks induction. This suggests that hypertrophic changes at the molecular level begin early in the time course of Myc expression and that these changes are temporarily regulated.
###end p 22
###begin title 23
Histological analysis of hearts.
###end title 23
###begin p 24
###xml 29 32 <span type="species:ncbi:10090">OFF</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
Myocardial sections from Myc-OFF (A, C) and Myc-ON (B, D) were stained with hematoxylin and eosin (A, B). Significant myocardial disarray is observed in Myc-ON mice (B). Trichrome staining (C, D) also reveals hypertrophied cardiac myocytes in Myc-ON mice with mild fibrosis (D). Original magnification: X 400 for A and B, X 200 for C and D. Scale bar = 50 microm.
###end p 24
###begin title 25
The change of molecular markers for cardiac hypertrophy by over expression of Myc.
###end title 25
###begin p 26
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Total ventricular RNA from mice with indicated Myc induction duration was analyzed by RT-PCR with specific primers. Each gene expression level was quantified and normalized with GAPDH expression level and expressed as a relative intensity.
###end p 26
###begin title 27
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Cell cycle re-entry in Myc-ON mice
###end title 27
###begin p 28
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g005">Figure 5</xref>
###xml 877 888 873 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g005">Figure 5E,F</xref>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
###xml 867 870 <span type="species:ncbi:10090">OFF</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
To test whether Myc expression induces cell cycle re-entry in adult cardiomyocytes, we measured the expression level of PCNA, Ki67, and cyclin D1, which increase during the cell cycle. We found that the expression of PCNA, Ki67, and cyclin D1 was strongly and specifically induced in cardiomyocytes in Myc-ON animals (Figure 5). In quantification analysis, we found that 38+/-2.8% of cardiomyocyte nuclei in Myc-ON animals were positive for Ki67. To confirm such aberrant cell cycle activity, we injected BrdU (50 mg/kg bodyweight) intraperitoneally 24 hrs before sacrificing the mice and DNA replication was measured by BrdU incorporation. Consistent with our PCNA, Ki67, and cyclin D1 data, a significant number of cardiomyocyte nuclei (23+/-2.8%) from Myc-ON mice were labeled with anti-BrdU antibody although no significant BrdU incorporation was observed in Myc-OFF mice (Figure 5E,F). Taken together, these data suggest that the cell cycle machinery is activated in cardiomyocytes after Myc expression.
###end p 28
###begin title 29
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Expression of cell cycle markers in the cardiomyocytes from Myc-ON mice.
###end title 29
###begin p 30
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 136 139 <span type="species:ncbi:10090">OFF</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 319 322 <span type="species:ncbi:10090">OFF</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
The expression of PCNA, Ki67 and cyclin D1 is dramatically increased in the nuclei of cardiomyocytes from Myc-ON mice (B, D, F). In Myc-OFF mice, no PCNA, Ki67 and a basal level of cyclin D1 is observed (A, C, E). DNA replication in cardiomyocyte in Myc-ON mice is confirmed by BrdU incorporation (H) compared with Myc-OFF mice (G). Original magnification: X 400. Scale bar = 50 microm.
###end p 30
###begin title 31
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Apoptosis is increased in Myc-ON mice
###end title 31
###begin p 32
###xml 235 246 235 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g006">Figure 6A,B</xref>
###xml 375 386 375 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g006">Figure 6C,D</xref>
###xml 140 143 <span type="species:ncbi:10090">OFF</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 225 228 <span type="species:ncbi:10090">OFF</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
We next examined the pathological effects of induction of Myc on apoptosis in cardiomyocytes. By comparing TUNEL staining in Myc-ON and Myc-OFF mice, TUNEL positive cardiomyocytes were increased in Myc-ON mice but not in Myc-OFF mice (Figure 6A,B). Consistent with this, the active form of caspase-3, which is increased in apoptotic cells, was also increased in Myc-ON mice (Figure 6C,D).
###end p 32
###begin title 33
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Increased apoptosis in Myc-ON mice.
###end title 33
###begin p 34
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 120 123 <span type="species:ncbi:10090">OFF</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 296 299 <span type="species:ncbi:10090">OFF</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
TUNEL positive nuclei (arrows) are specifically localized in the cardiomyocyte nuclei of Myc-ON mice (B) but not in Myc-OFF mice (A). The active form of caspase-3 was detected by anti-cleaved caspase-3 antibody and the increase number of positive cells is found in Myc-ON mice (D) but not in Myc-OFF mice (C). Original magnification: X 400. Scale bar = 50 microm.
###end p 34
###begin title 35
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Ultrastructural and functional alteration in mitochondria in Myc-ON mice
###end title 35
###begin p 36
###xml 195 203 195 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g003">Figure 3</xref>
###xml 335 346 335 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g007">Figure 7C,F</xref>
###xml 726 737 726 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g007">Figure 7D&#8211;G</xref>
###xml 1045 1049 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lehman1">[19]</xref>
###xml 1051 1055 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Russell1">[20]</xref>
###xml 1289 1300 1273 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g007">Figure 7A,B</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 716 719 <span type="species:ncbi:10090">OFF</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1256 1260 <span type="species:ncbi:10090">mice</span>
###xml 1279 1282 <span type="species:ncbi:10090">OFF</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
To confirm and extend the histological changes, the cellular ultrastructure of ventricular tissue from Myc-ON mice was examined by electron microscopy. Consistent with our histological analyses (Figure 3), Myc-ON mice showed a profound disruption of myofibrillar structure and, interestingly, a dramatic proliferation of mitochondria (Figure 7C,F). Since the disruption of myofibrils broadens the space mitochondria occupy and makes the measurement of total mitochondria in a fixed area difficult, sites containing relatively intact myofibrils were selected for morphometric measurements. Interestingly, increases in mitochondria number and density, but decreases in size, in Myc-ON mice are evident compared to Myc-OFF mice (Figure 7D-G). This result suggests that mitochondrial changes occur earlier than myofibril disruption and other pathological changes. In this regard, it is interesting to note that PGC-1alpha,a major regulatory molecule of mitochondrial proliferation, is known to play an important role inin hypertrophic cardiomyopathy[19], [20]. To determine the involvement of PGC-1alpha in Myc-ON mice, we analyzed the expression of PGC-1alpha and found that the level of PGC-1alpha was significantly increased in the cardiomyocytes in Myc-ON mice compared with Myc-OFF mice (Figure 7A,B). Taken together, our data suggest that mitochondrial alterations in cardiomyocytes are affected by Myc expression.
###end p 36
###begin title 37
###xml 68 72 <span type="species:ncbi:10090">mice</span>
The expression of PGC-1alpha and mitochondrial alteration in Myc-ON mice.
###end title 37
###begin p 38
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 205 208 <span type="species:ncbi:10090">OFF</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 394 397 <span type="species:ncbi:10090">OFF</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 599 602 <span type="species:ncbi:10090">OFF</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:262676">mito</span>
The expression of PGC-1alpha is examined by PGC-1alpha specific antibodies. The representative figures demonstrate strong induction of PGC-1alpha in the cardiomyocytes of Myc-ON mice (B) compared with Myc-OFF mice (A). Low-power electron microscopy reveals displacement of myofibrils in Myc-ON mice (C). The number and density of mitochondria are increased in Myc-ON mice (D) compared with Myc-OFF mice (E). Morphometric analysis demonstrated about 2.5 fold increase of mitochondria number and about 30% decrease of mitochondrial size in the cardiomyocytes of Myc-ON mice (p<0.05) compared with Myc-OFF mice (F). n: nucleus, m: myofibrils, mito: mitochondria. Original magnification: X 400 for A and B, X 30,000 for C, D and E.
###end p 38
###begin title 39
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Cardiac mitochondrial functional analysis in Myc mice
###end title 39
###begin p 40
###xml 431 438 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007172-t002">Table 2</xref>
###xml 1242 1249 1236 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007172-t002">Table 2</xref>
###xml 1490 1497 1484 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007172-t002">Table 2</xref>
###xml 1499 1507 1493 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g008">Figure 8</xref>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 400 403 <span type="species:ncbi:10090">OFF</span>
###xml 414 429 <span type="species:ncbi:10090">transgenic mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 614 617 <span type="species:ncbi:10090">OFF</span>
###xml 628 643 <span type="species:ncbi:10090">transgenic mice</span>
###xml 707 710 <span type="species:ncbi:10090">OFF</span>
###xml 914 917 <span type="species:ncbi:10090">OFF</span>
###xml 928 943 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1121 1126 <span type="species:ncbi:10090">mouse</span>
###xml 1160 1163 <span type="species:ncbi:10090">OFF</span>
Based on our ultrastructural findings, and since defects in mitochondrial metabolism contribute to the pathogenesis and progression of heart failure, we explored whether functional deficits in mitochondrial metabolism were associated with the observed changes in size and number of mitochondria in Myc-ON mice. Myc-ON expression led to a decrease in protein yield of mitochondria compared to the Myc-OFF or single transgenic mice (Table 2). Moreover, the specific activity of citrate synthase, a mitochondrial marker enzyme, was decreased in the mitochondria from Myc-ON mice compared to the mitochondria from Myc-OFF or single transgenic mice (Myc-ON 3540+/-160* mU/mg protein, n = 5 , p<0.05 vs. both Myc-OFF 4159+/-144, n = 5, and Single Tg 4105+/-156, n = 4). With glutamate plus malate as the donor of reducing equivalents to complex I, the rate of state 3 respiration was lower in Myc-ON compared to the Myc-OFF or single transgenic mice and state 4 respiration was also decreased in Myc-ON mitochondria compared to other groups. In contrast, the respiratory control ratio (RCR, state3/state4) was higher in Myc-ON mouse mitochondria compared to the Myc-OFF or single groups and there was no difference in the ADP/O ratio among groups (Table 2). With succinate plus rotenone as the complex II substrate, respiration was also decreased in Myc-ON mitochondria. The decreased oxidation in the presence of dinitrophenol localizes the defect to the mitochondrial electron transport chain (Table 2, Figure 8).
###end p 40
###begin title 41
###xml 219 222 <span type="species:ncbi:10090">OFF</span>
###xml 233 248 <span type="species:ncbi:10090">transgenic mice</span>
The expression of Myc leads to a decreased rate of dinitrophenol uncoupled respiration when glutamate+malate and succinate+rotenone were used as complex I and complex II substrates compared to the mitochondria from Myc-OFF or single transgenic mice (Single Tg) (Panel A).
###end title 41
###begin p 42
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 293 296 <span type="species:ncbi:10090">OFF</span>
###xml 337 340 <span type="species:ncbi:10090">OFF</span>
Myc did not affect the oxidation of TMPD-ascorbate (Panel A). Direct measurement of electron transport chain enzyme activity shows that Myc decreased activities of complex I, NCR (NADH cytochrome c oxidoreductase), and complex III (Panel B). Data are expressed as mean+/-SEM; * p<0.05 vs. Myc-OFF and Single Tg. n = 5 for Myc-ON and Myc-OFF, and n = 4 for Single Tg.
###end p 42
###begin title 43
The rate of oxidative phosphorylation (nAO/min/mg) in isolated mitochondria with glutamate and malate as complex I substrates.
###end title 43
###begin p 44
Mean+/-SEM.
###end p 44
###begin p 45
###xml 15 18 <span type="species:ncbi:10090">OFF</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
p<0.05 vs. Myc-OFF and Single Tg mice. RCR, respiratory control ratio; DNP, 2 mM ADP was used to measure state 3 respiration under conditions of saturating ADP.
###end p 45
###begin p 46
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 325 333 325 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g008">Figure 8</xref>
###xml 667 675 667 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g008">Figure 8</xref>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Chen1">[22]</xref>
###xml 636 639 <span type="species:ncbi:10090">OFF</span>
###xml 650 665 <span type="species:ncbi:10090">transgenic mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
###xml 1135 1139 <span type="species:ncbi:10090">mice</span>
Decreases in glutamate or succinate oxidation can be due to defects at complex III or complex IV (cytochrome oxidase). In this regard, TMPD-ascorbate donates electrons to cytochrome oxidase via cytochrome c and, importantly, unchanged TMPD oxidation excludes a defect at complex IV and further implicates upstream complexes (Figure 8). To further localize the defective sites within the electron transport chain, we directly measured the activities of complex I, complex II, and complex III and, consistent with above data, the conditional expression of Myc (Myc-ON) led to decreased activities of complex I and NCR compared to the Myc-OFF or single transgenic mice (Figure 8). NCR measures complex I-III activity with complex I considered to be the rate controlling step and, as such, the decreased rate of NCR supports a complex I defect in the electron transport chain in Myc-ON mice. To further dissect the defect within complex I, we determined the activity of NFR (a proximal part of complex I) [22]. The activity of NFR was unchanged in Myc-ON mice, indicating that the defect is distal to the first part of complex I in Myc-ON mice.
###end p 46
###begin p 47
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lesnefsky1">[23]</xref>
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007172-g009">Figure 9</xref>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 456 457 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 533 534 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 647 649 647 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aa</italic>
###xml 649 650 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 687 694 687 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007172-t003">Table 3</xref>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
Complex II activity was not altered by Myc-ON gene expression (data not shown) and the decrease in succinate driven respiration without a change in complex II activity coupled with normal oxidation of TMPD-ascorbate suggests the presence of a defect at complex III [23]. Direct measurements confirmed that the activity of complex III was significantly (p<0.05) decreased in Myc-ON mice (Figure 9). Complex III has three catalytic subunits: cytochromes b, c1 and the iron-sulfur protein and, interestingly, the decrease of cytochrome b content without affecting cytochrome c1 content was observed in Myc-ON mice and the content of cytochrome c and aa3 were also decreased in Myc-ON mice (Table 3). Since each complex III monomer contains a single cytochrome b subunit, we calculated the complex III turnover number using the ratio of complex III activity/cytochrome b content. The decreased complex III turnover in Myc-ON mice mitochondria suggests that the decrease in respiration through complex III in Myc-ON mice was due to a decreased content of complex III in mitochondria as well as a decreased activity of complex III per each monomer.
###end p 47
###begin title 48
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 83 86 <span type="species:ncbi:10090">OFF</span>
###xml 105 120 <span type="species:ncbi:10090">transgenic mice</span>
The complex III turnover is decreased in Myc-ON mice (n = 5) compared with the Myc-OFF (n = 5) or single transgenic mice (Single Tg) (n = 4).
###end title 48
###begin p 49
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 170 173 <span type="species:ncbi:10090">OFF</span>
###xml 184 199 <span type="species:ncbi:10090">transgenic mice</span>
Complex III turnover (sec-1) = complex III activity (nmol/mg protein/sec)/cytochrome b content (nmol/mg protein). Data are expressed as mean+/-SEM; dagger p<0.05 vs. Myc-OFF or single transgenic mice (Single Tg).
###end p 49
###begin title 50
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Cytochrome contents (nmol/mg protein) in isolated mouse heart mitochondria.
###end title 50
###begin p 51
Mean+/-SEM.
###end p 51
###begin p 52
###xml 23 26 <span type="species:ncbi:10090">OFF</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
p<0.05 or 0.01 vs. Myc-OFF and Single Tg mice.
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 1185 1189 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Zhong1">[24]</xref>
###xml 1252 1256 1252 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Xiao1">[25]</xref>
###xml 1608 1612 1608 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Xiao1">[25]</xref>
###xml 1614 1618 1614 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Hayashi1">[26]</xref>
###xml 1782 1786 1782 1786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Suzuki1">[27]</xref>
###xml 1788 1792 1788 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Barrick1">[28]</xref>
###xml 2167 2171 2167 2171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Zhong1">[24]</xref>
###xml 2173 2177 2173 2177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Xiao1">[25]</xref>
###xml 2577 2581 2577 2581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Kajstura1">[29]</xref>
###xml 2583 2587 2583 2587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Beltrami1">[30]</xref>
###xml 2927 2931 2927 2931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Kajstura1">[29]</xref>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 1240 1245 <span type="species:ncbi:10090">mouse</span>
###xml 1432 1437 <span type="species:ncbi:10090">mouse</span>
###xml 1533 1538 <span type="species:ncbi:10090">mouse</span>
###xml 1582 1587 <span type="species:ncbi:10090">mouse</span>
###xml 1885 1890 <span type="species:ncbi:10090">mouse</span>
###xml 2232 2247 <span type="species:ncbi:10090">transgenic mice</span>
In this study, to study the pathological role of Myc in cardiomyopathy and heart failure, we developed and characterized a newly established bi-transgenic mouse (MHC-Myc), which expresses Myc specifically in cardiomyocytes in a doxycycline-dependent manner. Since Myc is only expressed temporally during development, not in adult, in cardiomyocytes, the ability to regulate the expression of Myc after development was especially important in this study. In MHC-Myc mice, the expression of Myc is tightly regulated by doxycycline and no significant phenotype is observed until Myc was induced. However, induction of Myc (Myc-ON) for two weeks led to dramatic changes in the heart including an ectopic reactivation and expression of cell cycle markers in cardiomyocytes and mitochondrial perturbations that culminated in severe hypertrophy and, ultimately, death. These results strongly support the notion that increased Myc in adult cardiomyocytes induces cell cycle re-entry that leads to cardiomyopathy and is consistent with a previous report showing that the conditional inactivation of Myc attenuates cardiac hypertrophy induced by pressure overload and other hypertrophic stimuli [24]. However, in contrast to a previous Myc inducible mouse model [25], induction of Myc in MHC-Myc animals ultimately causes heart failure resulting in death in a relatively short duration (2-3 weeks). This difference is likely a consequence of mouse strain and expression level of Myc (Robb MacLellan, personal communication). While our MHC-Myc mouse is derived from FVB strain, the transgenic mouse line used by others [25], [26] is derived from C57Bl/6 and C3H mixed background. Since the effect of genetic background on the development of cardiomyopathy and heart failure is well documented [27], [28], it is likely that genetic factor(s) affect subsequent phenotypes. In addition, our MHC-Myc mouse studies here appear to have significantly higher levels of Myc expression and, consequently, a more robust phenotype than previous models. Supporting this, the number of cardiomyocytes re-entering the cell cycle in our MHC-Myc animals is much greater than reported previously [24], [25]. Therefore, the different phenotypes observed between transgenic mice is likely a consequence of the extent to which cardiomyocytes re-enter the cell cycle and progress into S phase, leading to the development of hypertrophy and consequent heart failure. Supporting this, recent studies have suggested that the adult myocardium is capable of limited cell division in certain pathological conditions [29], [30]. For instance, heart regions adjacent to a myocardial infarction show a significant increase of Ki-67 proliferation index, while no changes were noted distant from the lesion. Additionally, mitotic activity in cardiomyocytes is increased nearly 10-fold increase in end-stage ischemic heart disease and in idiopathic dilated cardiomyopathy [29]. Therefore, our data, in addition to other studies, strongly suggests that the reactivation of cell cycle in adult cardiomyocytes plays an important role in the development of cardiomyopathy and heart failure. This said, further study into the relationship to cell cycle re-entry as an adaptive or maladaptive process is clearly necessary.
###end p 54
###begin p 55
###xml 204 208 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Li1">[18]</xref>
###xml 433 437 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lehman1">[19]</xref>
###xml 439 443 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Russell1">[20]</xref>
###xml 638 642 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lehman1">[19]</xref>
###xml 923 927 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Russell1">[20]</xref>
###xml 1148 1152 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Russell1">[20]</xref>
###xml 1901 1905 1861 1865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Sihag1">[31]</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 747 752 <span type="species:ncbi:10090">mouse</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1744 1749 <span type="species:ncbi:9606">human</span>
###xml 1935 1940 <span type="species:ncbi:10090">mouse</span>
###xml 1977 1982 <span type="species:ncbi:9606">human</span>
###xml 1983 1991 <span type="species:ncbi:9606">patients</span>
Another important finding of our study is that Myc induces the morphological and functional alterations of mitochondria in MHC-Myc mice. Since PGC-1alpha related pathways can be directly regulated by Myc [18], we suspect that Myc-mediated PGC-1alpha regulation, which is tightly related with mitochondrial biogenesis and function, is a key pathway for the development of hypertrophic cardiomyopathy and heart failure in MHC-Myc mice [19], [20]. In support of this, cardiac-specific overexpression of PGC-1alpha, driven by the alpha-myosin heavy chain promoter, leads to marked mitochondrial proliferation, severe cardiomyopathy and death [19]. Further, of more physiologic relevance, is a model of inducible PGC-1alpha overexpression in the adult mouse, which leads to a more subtle increase in mitochondrial number and the development of a reversible cardiomyopathy, with both systolic and diastolic functional impairment [20]. The potential mechanism(s) of mitochondrial-mediated cardiac dysfunction by PGC-1alpha overexpression likely involves defects in mitochondrial oxidative metabolism or the increased production of reactive oxygen species [20]. Consistent with this notion, the increase of PGC-1alpha in our MHC-Myc mice was concomitant with an increase in mitochondrial number, a decrease in mitochondria size, and a reduction in the activity of mitochondrial oxidative metabolism. While the mechanistic basis for PGC-1alpha-mediated cardiomyopathy is unclear, it is likely that dysregulated mitochondrial metabolism and/or morphological alteration play an important role in the development of cardiomyopathy and heart failure. Interestingly, a recent study demonstrated an increased level of PGC-1alpha, but not activity, in failing human hearts suggesting that, despite the increase of PGC-1alpha, downstream pathways were disturbed by other mechanisms to induce mitochondrial pathologies [31]. Our observations in MHC-MYC mouse are consistent with these data from human patients as we also observed an increase of level of PGC-1alpha accompanied by functional deficits in mitochondrial energy metabolism.
###end p 55
###begin p 56
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Loeffen1">[14]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Jarreta1">[15]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-VanCoster1">[16]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Jarreta1">[15]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Buchwald1">[32]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Raje1">[36]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-MarinGarcia1">[33]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-MarinGarcia2">[34]</xref>
###xml 1332 1336 1332 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lucas1">[17]</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
Notably, it is well established that defects in electron transport chain complexes I [14], complex III [15] and IV [16] lead to dilated cardiomyopathy in human patients. Moreover, the enzyme activity of electron transport chain complexes is decreased in hearts explanted from patients with end-stage heart failure [15], [32]-[36] and, importantly, end-stage heart failure also results in re-expression of Myc as well as decreases in complexes I, III, and IV, and mutations in mtDNA [33], [34]. Therefore, the functional defect in mitochondrial energy metabolism in MHC-Myc mice is likely a key mechanism for the development of cardiac phenotypes such as hypertrophy and heart failure. Regarding this, the smaller size of mitochondria may also explain the defect in mitochondrial function coupled with an increase of mitochondrial number. In fact, our biochemical analyses show that citrate synthase, amount and activity, is decreased in MHC-Myc mice. Since citrate synthase is a mitochondrial matrix marker enzyme, reflecting relative mitochondrial abundance and purity, these results suggest that Myc may increase the number of immature mitochondria. The decrease in cytochrome content and multiple defects in the electron transport chain further supports the notion that mitochondrial development may be incomplete in Myc-ON mice [17]. Collectively, these findings could explain increased mitochondrial number coupled with decreased activities of citrate synthase, complex I, and complex III.
###end p 56
###begin p 57
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
In conclusion, our findings using a novel transgenic mouse with cardiomyocyte-specific expression of Myc (MHC-Myc mice) clearly demonstrate that increased expression of Myc can induce hypertrophic cardiomyopathy and heart failure in vivo. Mechanistically, dysregulation of cell cycle and concomitant mitochondrial alteration are likely key pathogenic mechanisms for subsequent hypertrophy-induced heart failure. As such, therapeutics targeted toward Myc, cell cycle re-activation, and/or mitochondrial dysfunction may provide opportunities for the treatment and management of cardiomyopathies.
###end p 57
###begin title 58
Materials and Methods
###end title 58
###begin title 59
Animals
###end title 59
###begin p 60
###xml 326 330 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Valencik1">[21]</xref>
###xml 350 353 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Felsher1">[9]</xref>
###xml 682 692 674 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 77 92 <span type="species:ncbi:10090">transgenic mice</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 991 996 <span type="species:ncbi:10090">mouse</span>
We used the reverse tetracycline transactivator (rtTA) system to generate bi-transgenic mice that inducibly overexpress human c-Myc cDNA under the control of alpha-myosin heavy chain (MHC) promoter to drive high transgene expression specifically in the cardiomyocyte. All MHC-Myc mice were derived from crossing alphaMHC-rtTA [21] and tet-o-Myc mice [9], and the genotypes of the F1 progeny confirmed by PCR. All mice in this study were conceived and raised without doxycycline to prevent any potential developmental consequences from the expression of Myc. To induce Myc expression in cardiomyocytes, doxycycline-containing food (200 mg/kg; Bio-Serve, Frenchtown, NJ) was provided ad libitum to animals and sequential echocardiograms were performed. Thereafter, animals were sacrificed for further pathophysiological analysis. Importantly, in preliminary experiments, we found that the doxycycline diet had no effect on single transgenic littermates, which were used as a single transgenic mouse control, on the development of cardiac hypertrophy nor other biochemical analyses performed in this study. All study protocols were approved by Case Western Reserve University School of Medicine Institutional Animal Care and Use Committee.
###end p 60
###begin title 61
Immunocytochemistry
###end title 61
###begin p 62
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
###xml 380 386 <span type="species:ncbi:9986">rabbit</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 513 519 <span type="species:ncbi:9986">rabbit</span>
###xml 596 602 <span type="species:ncbi:9986">rabbit</span>
Formalin fixed hearts were processed and embedded in paraffin. Six microm thick serial sections were cut, mounted onto slides and rehydrated according to standard protocols. Immunocytochemistry was performed by the ABC method according to the manufacturer's protocol (Vector Lab, Burlingame, CA). Anti-PCNA mouse monoclonal antibody (Santa Cruz Biotech, Santa Cruz, CA), anti-Myc rabbit monoclonal antibody (Epitomics, Burlingame, CA), anti-Ki67 mouse monoclonal antibody (Dako, Carpinteria, CA), anti-PGC-1alpha rabbit polyclonal antibody (Santa Cruz Biotech, Santa Cruz, CA) and anti-Cyclin D1 rabbit antibody (Thermo Scientific, Waltham, MA) were used. Antibody reactivity was localized using 3-3'-diaminobenzidine as a chromogen (Dako, Carpinteria, CA). To exclude the possibility of non-specific reaction, all the immunocytochemistry experiments contained at least one sample without a primary antibody. Haemotoxylin and eosin staining and Trichrome staining were also performed for routine histochemical and morphological analyses. Quantification of Ki67- and BrdU-positive cardiomyocytes was performed on slides stained and counterstained with haematoxylin. Four areas of kleft venticles were randomly selected on an Axiophot microscope (Zeiss, Thornwood, NY) and at least 100 positive cardiomyocytes were counted per area. Percent positive was calculated by dividing the percent positive nuclei by total number of cardiomyocytes counted per experimental group (n = 3).
###end p 62
###begin title 63
RT-PCR
###end title 63
###begin p 64
###xml 908 934 878 904 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTGGATCACCTTCTGCTGG-3&#8242;</named-content>
###xml 947 974 917 944 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTCTTGACATTTCTCCTCGG-3&#8242;</named-content>
###xml 1019 1046 989 1016 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATCACCCTGGGCTTCTTCCT-3&#8242;</named-content>
###xml 1059 1086 1029 1056 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGGCTCCAATCCTGTCAATC-3&#8242;</named-content>
###xml 1119 1152 1089 1122 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCG GCA TGG ATC TCC TGA AGG-3&#8242;</named-content>
###xml 1165 1198 1135 1168 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCC AGG CAG AGT CAG AAA CTG-3&#8242;</named-content>
###xml 1226 1257 1196 1227 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGTTCCAGTATGACTCCACTCAGG-3&#8242;</named-content>
###xml 1270 1301 1240 1271 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAAGACACCAGTAGACTCCACGACA-3&#8242;</named-content>
mRNA was isolated from heart tissues using an RNeasy kit (Qiagen, Valencia, CA). RT-PCR was carried out using the RETROscript RT-PCR kit (Ambion, Austin, TX) according to the manufacturer's instructions. Briefly, purified total RNA (100 ng) was reverse transcribed with cloned MMLV reverse transcriptase (50 U) by incubating at 44degreesC for 60 min, followed by heating at 92degreesC for 10 min. The resulting single-stranded cDNA was then amplified using a pair of primers for each target gene (25 pmol) and Taq DNA polymerase (2.5 U; Roche, Indianapolis, IN) for the indicated number of cycles of amplification (30 sec at 94degreesC for denaturing, 30 sec at 61degreesC for primer annealing, and 30 sec at 72degreesC for primer extension). The RT-PCR products were then subjected to electrophoresis in a 1.5% agarose gel. The nucleotide sequence used for each primer was as follows: for c-Myc: 5'-primer, 5'-TCTGGATCACCTTCTGCTGG-3'; 3'-primer, 5'-CCTCTTGACATTTCTCCTCGG-3', for atrial natriuretic peptide: 5'-primer, 5'-CATCACCCTGGGCTTCTTCCT-3'; 3'-primer, 5'-TGGGCTCCAATCCTGTCAATC-3', for brain natriuretic peptide: 5'-GCG GCA TGG ATC TCC TGA AGG-3'; 3'-primer, 5'-CCC AGG CAG AGT CAG AAA CTG-3', and for GAPDH: 5'-primer, 5'-ATGTTCCAGTATGACTCCACTCAGG-3'; 3'-primer, 5'-GAAGACACCAGTAGACTCCACGACA-3'.
###end p 64
###begin title 65
TUNEL analysis
###end title 65
###begin p 66
Detection of 3'-OH termini of DNA strand breaks was performed on paraffin sections using the In Situ Cell Death Detection Kit (Roche, Indianapolis, IN) following the recommendations of the manufacturer. Briefly, the tissue sections were treated with proteinase K (20 microg/ml in 10 mM Tris-HCl, pH 7.4) for 30 min at 37degreesC after rehydration. After rinsing slides with phosphate buffered saline, TUNEL reaction mixture containing terminal deoxynucleotidyl transferase and fluorescence labeled nucleotide was applied for 1 hr at 37degreesC. Positive signals were observed directly using fluorescence microscopy. Positive and negative controls were run in parallel on adjacent sections to confirm the specificity of the assay.
###end p 66
###begin title 67
BrdU incorporation analysis
###end title 67
###begin p 68
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 534 537 <span type="species:ncbi:10116">rat</span>
DNA synthesis was directly examined by analysis of 5-bromo-2'-deoxyuridine (BrdU) incorporation. For this experiment, 50 mg/kg of the thymidine analog BrdU (Sigma, St. Louis, MO) was intraperitoneally injected into each mouse. One day after injection, hearts were removed and embedded in paraffin, sectioned, and mounted on slides. The sections were treated with 2N hydrochloric acid for 2 hr and then washed two times with 1x Tris-buffered saline (3 min each) to neutralize the acid. Incorporated BrdU was detected with an anti-BrdU rat monoclonal antibody (Abcam, Cambridge, MA) diluted 1:200 by the ABC method as described above.
###end p 68
###begin title 69
Electron microscopy
###end title 69
###begin p 70
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Cash1">[37]</xref>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Zhu1">[38]</xref>
Electron microscopy on tissue sections was performed as described previously [37], [38]. Briefly, tissue was immediately fixed in 1.5% glutaraldehyde in cacodylate buffer, pH 7.4 for 1 hour at room temperature and postfixed in 1% osmium tetroxide for 1 hour. After dehydration in graded ethanol and propylene oxide, the tissue was embedded in epoxy resin, then sectioned at silver interference color. Thin sections were stained with uranyl acetate and lead citrate, and examined in a JEOL 1200EX electron microscope (Tokyo, Japan).
###end p 70
###begin title 71
Echocardiographic analysis
###end title 71
###begin p 72
###xml 1427 1431 1415 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Morgan1">[39]</xref>
###xml 1666 1667 1654 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1671 1672 1659 1660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1762 1763 1750 1751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 617 621 <span type="species:ncbi:10090">Mice</span>
Mice were weighed and anesthetized with isoflurane (induced at 3% and maintained at approximately1% by nosecone). After shaving the chest, the extremities were secured to a warming pad (Braintree Scientific, Braintree, MA) with paper tape and needle electrodes were connected to a preamplifier to simultaneously record a single lead electrocardiogram. Pre-warmed, centrifuged (to eliminate air bubbles) ultrasound transmission gel was applied to the chest and 2D-directed M-mode and Doppler echocardiographic studies were performed using a 15 MHz (15L8) linear array transducer (Sequoia, Siemens, Mountain View, CA). Mice were imaged in the shallow left lateral decubitus position and short and orthogonal long axis and apical views were obtained. The M-mode dimensions included the end-diastolic (LV EDD) and end-systolic (LV ESD) diameters [taken from the short axis at the level of the largest left ventricle (LV) diameter], end-diastolic posterior (EDPWTh) and end-diastolic septal (EDSWTh) wall thicknesses, the LV outflow tract diameter (LVOT) and left atrial and, aortic root dimensions. Doppler variables included the peak and velocity time integral (vti) of aortic flow, and aortic ejection time. Simultaneous transmitral and LV outflow velocities were obtained for calculation of the relatively heart rate-independent myocardial performance index (MPI), which is a measure of combined systolic and diastolic function [39]. The MPI is the sum of the isovolumic contraction and relaxation times divided by the aortic ejection time. Other derived echo indices included the LV fractional shortening (FS = (EDD-ESD)/EDD), LV mass [LVM = 1.06*(EDD+EDPWTh*EDSWTh)3-EDD3)], relative wall thickness [RWT = (EDWTh+EDSWTh)/EDD)], and cardiac output [CO = (LVOT/2)2*aortic vti*heart rate]. LV mass was normalized by the body weight. Studies were performed by a sonographer who was blinded to genotype.
###end p 72
###begin title 73
Mitochondria isolation
###end title 73
###begin p 74
###xml 379 380 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 384 385 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1302 1306 1287 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lesnefsky1">[23]</xref>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 566 572 <span type="species:ncbi:9913">bovine</span>
###xml 1269 1275 <span type="species:ncbi:9913">bovine</span>
A single population of cardiac mitochondria, consisting of a combination of subsarcolemmal and interfibrillar mitochondria, was isolated using protease treatment. Cardiac tissue from a pool of 3 to 5 mouse hearts was finely minced and placed in buffer A [containing (in mM) 100 KCl, 50 MOPS, 1 EGTA [ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid], 5 MgSO4*7 H2O, and 1 ATP; pH 7.4] at 4degreesC. The minced tissue was homogenized and incubated for 30 sec at 4degreesC in the presence of protease (5 mg/g wet tissue). Buffer B (Buffer A+0.2% bovine serum albumin) was added to neutralize the protease reaction. The mixed homogenate was quickly centrifuged at 8,000 g for 10 min, and the supernatant was discarded. The pellets were re-suspended in buffer B, centrifuged at 500 g for 10 min, and the supernatant saved for mitochondria isolation. The pellets were resuspended one more time, washed in Buffer B, re-centrifuged, and the remaining pellet discarded. The combined supernatants were centrifuged at 3,000 g to sediment mitochondria, which were sequentially washed with buffer B followed by KME (100 mM KCl, 50 mM MOPS, and 0.5 mM EGTA). Mitochondria were suspended in KME and the protein content was determined by the biuret method using bovine serum album as a standard [23].
###end p 74
###begin title 75
Mitochondrial oxidative phosphorylation and oxidase activities
###end title 75
###begin p 76
###xml 98 102 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lesnefsky1">[23]</xref>
###xml 193 194 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 197 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 673 677 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lesnefsky1">[23]</xref>
Oxygen consumption in mitochondria was measured using a Clark-type oxygen electrode at 30degreesC [23]. Mitochondria were incubated in a buffer [containing (in mM) 80 KCl, 50 MOPS, 1 EGTA, 5 KH2PO4, and 1 mg/ml BSA, at pH 7.4]. Glutamate+malate (complex I substrate), succinate (complex II substrate), and TMPD (N,N,N',N' tetramethyl p-phenylenediamine)-ascorbate (complex IV substrate) were used as donors to specific sites in the electron transport chain. Rotenone (5 uM) was used with succinate and TMPD-ascorbate to prevent reverse electron flow. State 3 (ADP-stimulated), state 4 (ADP-limited) respiration, respiratory control ratio, and the ADP/O ratio were measured [23]. Dinitrophenol (0.2 mM) was used to determine the maximal rate of uncoupled respiration independent of the phosphorylation apparatus including complex V.
###end p 76
###begin title 77
Electron transport chain and citrate synthase enzyme activities
###end title 77
###begin p 78
###xml 133 137 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Hoppel1">[40]</xref>
###xml 138 142 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007172-Lesnefsky2">[42]</xref>
###xml 160 161 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
The following enzyme activities were measured at 37degreesC in detergent-solubilized mitochondria using previously described methods [40]-[42]: NADH-cytochrome c reductase (NCR), rotenone-sensitive; NADH-decylubiquinone reductase, rotenone sensitive (complex I); NADH ferricyanide reductase (NFR); Succinate-decylubiquinone reductase (complex II); Decylubiquinol cytochrome c oxidoreductase (complex III); and citrate synthase.
###end p 78
###begin title 79
Statistics
###end title 79
###begin p 80
Statistical comparisons were performed by parametric analysis using a one-way analysis of variance (ANOVA) and/or Students' t-test, as appropriate, to determine significant differences across experimental groups. The null hypothesis was rejected at p<0.05.
###end p 80
###begin title 81
References
###end title 81
###begin article-title 82
###xml 125 128 <span type="species:ncbi:10116">rat</span>
Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart.
###end article-title 82
###begin article-title 83
Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
###end article-title 83
###begin article-title 84
c-myc gene expression is localized to the myocyte following hemodynamic overload in vivo.
###end article-title 84
###begin article-title 85
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila myc regulates cellular growth during development.
###end article-title 85
###begin article-title 86
The Myc/Max/Mad network and the transcriptional control of cell behavior.
###end article-title 86
###begin article-title 87
The myc oncogene: MarvelouslY Complex.
###end article-title 87
###begin article-title 88
c-MYC: more than just a matter of life and death.
###end article-title 88
###begin article-title 89
c-Myc target genes involved in cell growth, apoptosis, and metabolism.
###end article-title 89
###begin article-title 90
Reversible tumorigenesis by MYC in hematopoietic lineages.
###end article-title 90
###begin article-title 91
Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations.
###end article-title 91
###begin article-title 92
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
C-myc protooncogene modulates cardiac hypertrophic growth in transgenic mice.
###end article-title 92
###begin article-title 93
ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure.
###end article-title 93
###begin article-title 94
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy.
###end article-title 94
###begin article-title 95
###xml 33 41 <span type="species:ncbi:9606">children</span>
Isolated complex I deficiency in children: clinical, biochemical and genetic aspects.
###end article-title 95
###begin article-title 96
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy.
###end article-title 96
###begin article-title 97
Mitochondrial cytopathies and neuromuscular disorders.
###end article-title 97
###begin article-title 98
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.
###end article-title 98
###begin article-title 99
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis.
###end article-title 99
###begin article-title 100
Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.
###end article-title 100
###begin article-title 101
Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner.
###end article-title 101
###begin article-title 102
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.
###end article-title 102
###begin article-title 103
###xml 114 117 <span type="species:ncbi:10116">rat</span>
Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria.
###end article-title 103
###begin article-title 104
Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria.
###end article-title 104
###begin article-title 105
Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway.
###end article-title 105
###begin article-title 106
Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis.
###end article-title 106
###begin article-title 107
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Over expression of FGF7 enhances cell proliferation but fails to cause pathology in corneal epithelium of Kerapr-rtTA/FGF7 bitransgenic mice.
###end article-title 107
###begin article-title 108
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Genetic modifier loci affecting survival and cardiac function in murine dilated cardiomyopathy.
###end article-title 108
###begin article-title 109
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy.
###end article-title 109
###begin article-title 110
###xml 54 60 <span type="species:ncbi:9606">humans</span>
Myocyte proliferation in end-stage cardiac failure in humans.
###end article-title 110
###begin article-title 111
###xml 14 19 <span type="species:ncbi:9606">human</span>
Evidence that human cardiac myocytes divide after myocardial infarction.
###end article-title 111
###begin article-title 112
###xml 81 86 <span type="species:ncbi:9606">human</span>
PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.
###end article-title 112
###begin article-title 113
###xml 54 59 <span type="species:ncbi:9606">human</span>
Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy.
###end article-title 113
###begin article-title 114
Is age a contributory factor of mitochondrial bioenergetic decline and DNA defects in idiopathic dilated cardiomyopathy?
###end article-title 114
###begin article-title 115
A point mutation in the cytb gene of cardiac mtDNA associated with complex III deficiency in ischemic cardiomyopathy.
###end article-title 115
###begin article-title 116
Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy.
###end article-title 116
###begin article-title 117
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma.
###end article-title 117
###begin article-title 118
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.
###end article-title 118
###begin article-title 119
Neuroprotective properties of Bcl-w in Alzheimer disease.
###end article-title 119
###begin article-title 120
###xml 86 90 <span type="species:ncbi:10116">rats</span>
Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction.
###end article-title 120
###begin article-title 121
Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy.
###end article-title 121
###begin article-title 122
###xml 165 169 <span type="species:ncbi:10116">rats</span>
Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria.
###end article-title 122
###begin article-title 123
Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the National Institutes of Health [AG028679 (MAS), AG031364 (MAS), AG15885 (EJL)] and Medical Research Service Department of Veterans Affairs (EJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 125

